PHLT Lawsuits

Shareholder Alert: The Ademi Firm Investigates Whether Performant Healthcare Inc. Is Obtaining a Fair Price for Its Public Shareholders

Published August 08, 2025 at 12:23 PM

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Performant (NASDAQ: PHLT) for possible breaches of fiduciary duty and other violations of law in its transaction with Machinify. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Performant will receive $7.75 in cash for each share of common stock outstanding, or a

Related Questions

How might the investigation affect the timing and certainty of the transaction closing? What is the likelihood that the investigation will result in a material change to the $7.75 per‑share cash offer? What are the potential legal or regulatory outcomes that could alter or block the transaction? What are the potential costs (legal, settlement, etc.) that could be passed to shareholders? How will the investigation impact liquidity and short‑term price volatility of PHLT? Is the $7.75 cash consideration above, at, or below fair market value compared to recent trading prices and comparable transactions? Could the investigation expose other corporate governance or fiduciary issues that might affect future valuations? Will the investigation trigger any shareholder‑approval requirements or affect existing shareholder rights? How might this news influence institutional and retail investor sentiment toward PHLT? What is the expected timeline for the investigation and any possible delay to the cash distribution?